Comparing photon and proton based hypofractioned SBRT for prostate cancer accounting for robustness and realistic treatment deliverability

To investigate whether photon or proton based SBRT is the preferred modality for high dose hypofractionation prostate cancer treatment. Achievable dose distributions were compared when uncertainties in target positioning and range uncertainties were appropriately accounted for.
UroToday